证券代码：603379 证券简称：三美股份 公告编号：2023-033 浙江三美化工股份有限公司（以下简称"公司"）于 2023 年 8 月 10 日以现场 结合通讯表决方式在公司会议室召开第六届董事会第六次会议。会议通知已于 2023 年 8 月 4 日以书面、电子邮件等方式向全体董事发出。本次会议应出席董 事 9 人，实际出席董事 9 人。本次会议由董事长胡淇翔主持，部分高管列席会议。 本次会议召开符合《公司法》和《公司章程》的有关规定。 经与会董事审议，本次会议以投票表决的方式审议通过了以下议案： 一、审议通过《关于增加 2023 年度日常关联交易额度的议案》 内容详见 2023 年 8 月 10 日公司在上海证券交易所网站 www.sse.com.cn 以 及 2023 年 8 月 11 日在《上海证券报》披露的《浙江三美化工股份有限公司关于 增加 2023 年度日常关联交易额度的公告》。 表决结果：同意 8 票，反对 0 票，弃权 0 票，关联董事胡淇翔回避表决。 独立董事事前认可意见：本次增加 2023 年度日常关联交易额度，系公司根 据 35KV 变电站的运行及使用情况，拟向三联实业提供电力而发 ...

关于第六届董事会第六次会议审议事项的独立意见 根据《公司法》《证券法》《上市公司独立董事规则》《上海证券交易所股票 上市规则》和三美股份《公司章程》等有关规定，我们作为三美股份独立董事， 对公司第六届董事会第六次会议审议的相关事项发表如下意见： 浙江三美化工股份有限公司独立董事 一、关于增加 2023 年度日常关联交易额度的独立意见 公司在保障自身用电的前提下，拟向三联实业提供电力，是基于提高 35KV 变电站的利用率考虑的。本次增加 2023 年度日常关联交易额度，关联交易价格 参考市场价格协商定价；关联董事回避表决，审议程序符合相关规定；公司业务 未对关联方形成较大依赖，不影响上市公司独立性，不存在损害公司及股东、尤 其是中小股东利益的情形。同意本次关联交易事项。 （以下无正文） (本页无正文，为《浙江三美化工股份有限公司独立董事关于第六届董事会第六次 会议审议事项的独立意见》之签字页 ) 独立董事签字: 张陶勇 夏祖兴 徐何生 2023 年 8 月 10 日 （本页无正文，为《浙江三美化工股份有限公司独立董事关于第六届董事会第六次 会议审议事项的独立意见》之签字页) 独立董事签字: 夏祖兴 徐何生 20 ...

证券代码：603379 证券简称：三美股份 公告编号：2023-036 浙江三美化工股份有限公司 关于增加 2023 年度日常关联交易额度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、日常关联交易的基本情况 （一）日常关联交易的审议程序 浙江三美化工股份有限公司（以下简称"三美股份"或"公司"）于 2023 年 8 月 10 日召开第六届董事会第六次会议，审议通过了《关于增加 2023 年度日常关 联交易额度的议案》，表决结果为：同意 8 票、反对 0 票、弃权 0 票，关联董事 胡淇翔回避表决。 公司独立董事进行了事前审核，认为：本次增加 2023 年度日常关联交易额 度，系公司根据 35KV 变电站的运行及使用情况，拟向浙江武义三联实业发展有 限公司（以下简称"三联实业"）提供电力而发生的，有利于提高该固定资产的 利用率。关联交易价格参考市场价格协商定价，具备公允性，不存在损害公司及 股东、尤其是中小股东利益的情形。同意本次关联交易事项，并提交董事会审议。 经董事会审议，公司独立董事认为：公司 ...

证券代码：603379 证券简称：三美股份 公告编号：2023-034 浙江三美化工股份有限公司 第六届监事会第五次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三美化工股份有限公司（以下简称"公司"）于 2023 年 8 月 10 日以现场 表决方式在公司会议室召开第六届监事会第五次会议。会议通知已于 2023 年 8 月 4 日以书面、电子邮件等方式向全体监事发出。本次会议应出席监事 3 人，实 际出席监事 3 人。监事会主席陈侃主持会议，董事会秘书列席会议。本次会议召 开符合《公司法》和《公司章程》的有关规定。 经与会监事审议，本次会议以投票表决的方式审议通过了以下议案： 一、审议通过《关于增加 2023 年度日常关联交易额度的议案》 2023 年 8 月 10 日 内容详见 2023 年 8 月 10 日公司在上海证券交易所网站 www.sse.com.cn 以 及 2023 年 8 月 11 日在《上海证券报》披露的《浙江三美化工股份有限公司关于 增加 2023 年度日常关联交易额度的公告》。 监 ...

关于三美股份股票交易异常波动有关情况的回函 浙江三美化工股份有限公司： 本人于 2023 年 8 月 9 日收到贵公司发来的《关于三美股份股票交易异常波 动的询证函》。经本人自查确认，回复如下： 本人作为浙江三美化工股份有限公司（以下简称"三美股份"或"公司"）的实 际控制人，截至目前，不存在影响公司股票交易异常波动的重大事项，不存在应 披露而未披露的重大信息，包括但不限于涉及上市公司的重大资产重组、股份发 行、收购、债务重组、业务重组、资产剥离、资产注入、股份回购、股权激励、 破产重整、重大业务合作、引进战略投资者等重大事项。在三美股份异常波动期 间，本人及一致行动人不存在买卖公司股票的情况。 特此回复。 胡淇翔 2023 年 8 月 9 日 本人于 2023 年 8 月 9 日收到贵公司发来的《关于三美股份股票交易异常波 动的询证函》。经本人自查确认，回复如下： 本人作为浙江三美化工股份有限公司（以下简称"三美股份"或"公司"）的控 股股东、实际控制人，截至目前，不存在影响公司股票交易异常波动的重大事项， 不存在应披露而未披露的重大信息，包括但不限于涉及上市公司的重大资产重组、 股份发行、收购、债务重组、 ...

证券代码：603379 证券简称：三美股份 公告编号：2023-032 浙江三美化工股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司股票于 2023 年 8 月 7 日、8 日、9 日连续 3 个交易日内收盘价格涨 幅偏离值累计达到 20%，根据《上海证券交易所交易规则》的有关规定，属于股 票交易异常波动的情形。 经公司自查，并向控股股东、实际控制人及其一致行动人书面问询，截 至本公告发布之日，公司确认不存在应披露而未披露的重大信息。 8 月 9 日下午，国家生态环境部大气环境司组织召开了《2024 年度全国 HFCs 配额总量设定与分配实施方案》（初稿）行业交流会。 本次会议仅为初稿的交流，《2024 年度全国 HFCs 配额总量设定与分配实施 方案》尚存在不确定性，具体落地方案，请以国家有关监管部门正式颁布为准。 敬请广大投资者注意投资风险，理性决策，审慎投资。 相关风险提示：2023 年 8 月 9 日，公司股票收盘价 31.60 元/股，动态市 盈率为 241.5 ...

Financial Performance - The company's operating revenue for Q1 2023 was RMB 777,604,061.17, a decrease of 34.12% compared to the same period last year[4] - The net profit attributable to shareholders was RMB 19,972,241.76, down 89.65% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 21,718,081.36, a decline of 87.66% compared to the previous year[4] - The basic earnings per share were RMB 0.03, reflecting a decrease of 90.63% year-on-year[4] - Total operating revenue for Q1 2023 was RMB 777.60 million, a decrease of 34% compared to RMB 1,180.42 million in Q1 2022[16] - Net profit for Q1 2023 was RMB 19.97 million, a significant decline of 90.6% from RMB 192.99 million in Q1 2022[17] - Total profit for Q1 2023 was RMB 26.11 million, down 89.8% from RMB 254.98 million in Q1 2022[17] Assets and Liabilities - Total assets at the end of the reporting period were RMB 6,286,080,232.07, down 2.23% from the end of the previous year[5] - The company's current assets totaled RMB 4,524,933,632.09, down from RMB 4,733,362,572.34, indicating a decrease of about 4.41%[12] - Total liabilities decreased to RMB 548,846,911.08 from RMB 720,106,748.11, a significant decline of approximately 23.8%[14] - The company's equity attributable to shareholders increased to RMB 5,737,233,320.99 from RMB 5,709,667,982.73, reflecting a slight increase of about 0.48%[15] Cash Flow - The company reported a net cash flow from operating activities of RMB 222,854,466.72, a decrease of 5.99% year-on-year[4] - Cash inflow from operating activities in Q1 2023 was RMB 782.22 million, down 31% from RMB 1,136.71 million in Q1 2022[19] - The net cash flow from operating activities was $222,854,466.72, a decrease of 6.1% compared to $237,046,946.14 in the previous period[20] - Cash outflow from operating activities totaled $559,365,928.72, down from $899,663,946.89, indicating a significant reduction in operational cash expenses[20] - The total cash and cash equivalents at the end of the period reached $3,622,900,826.13, an increase from $2,037,320,323.71, showing strong liquidity position[20] Operational Metrics - The decline in revenue and profit was primarily due to a decrease in both sales volume and sales prices[7] - The weighted average return on equity was 0.35%, a decrease of 3.23 percentage points compared to the previous year[4] - Research and development expenses increased to RMB 8.82 million in Q1 2023, up 36% from RMB 6.49 million in Q1 2022[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,810[9] Other Financial Activities - The company reported a foreign currency translation loss of RMB 110.88 in Q1 2023, compared to a loss of RMB 873.80 in Q1 2022[18] - Investment loss for Q1 2023 was RMB 1.86 million, compared to a gain of RMB 2.60 million in Q1 2022[17] - Other income for Q1 2023 was RMB 1.27 million, a decrease of 48.7% from RMB 2.48 million in Q1 2022[17] - The company has not participated in margin financing or securities lending activities during the reporting period[10] - There are no significant new product developments or market expansion strategies mentioned in the report[11]

Financial Performance - The company's operating revenue for 2022 was approximately ¥4.77 billion, representing a year-over-year increase of 17.84% compared to ¥4.05 billion in 2021[16]. - The net profit attributable to shareholders for 2022 was approximately ¥485.57 million, a decrease of 9.44% from ¥536.17 million in 2021[16]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥451.10 million, down 6.79% from ¥483.98 million in 2021[16]. - The net cash flow from operating activities for 2022 was approximately ¥628.73 million, an increase of 158.22% compared to ¥243.49 million in 2021[16]. - The total assets at the end of 2022 were approximately ¥6.43 billion, reflecting a 6.26% increase from ¥6.05 billion at the end of 2021[16]. - The net assets attributable to shareholders at the end of 2022 were approximately ¥5.71 billion, up 7.97% from ¥5.29 billion at the end of 2021[16]. - The weighted average return on equity decreased by 1.46 percentage points to 8.84%[1]. - The company reported a basic earnings per share of CNY 0.80, down 9.09% from CNY 0.88 in the previous year[1]. Dividend Policy - The company plans to distribute a cash dividend of 2.39 CNY per 10 shares, totaling approximately 145.90 million CNY (including tax) based on a total share capital of 610,479,037 shares as of December 31, 2022[2]. - The company has established a cash dividend policy, stating that the total cash dividends should not be less than 20% of the audited net profit attributable to shareholders in the current year[156]. - The cash dividend represents 19.36% of the net profit attributable to ordinary shareholders in the consolidated financial statements, which amounted to 536,168,573.50 RMB[161]. - The total dividend amount, including cash buybacks, is 268,605,244.78 RMB, accounting for 50.10% of the net profit attributable to ordinary shareholders[161]. - The company maintains a cash dividend policy where at least 40% of profits are distributed as cash dividends during the mature stage of development with significant capital expenditures[157]. - The company has not made any adjustments to its profit distribution policy during the reporting period[158]. Corporate Governance - The company has established a robust governance structure, holding three shareholder meetings during the reporting period to ensure transparency and protect shareholder rights[122]. - The company held 6 board meetings during the reporting period, with 9 current directors, including 3 independent directors, ensuring compliance with legal regulations[123]. - The company established a comprehensive performance evaluation system for senior management, linking compensation closely to performance, with core management holding shares in the company[125]. - The company maintained strict independence from its controlling shareholders and related parties in personnel, assets, finance, and operations, ensuring independent accounting and risk management[126]. - The company engaged in effective communication with investors through various channels, ensuring fair treatment of institutional and retail investors[126]. - The company emphasized environmental protection and social responsibility, increasing investment in environmental governance and supporting community welfare initiatives[126]. Risk Management - The company has outlined potential risks and corresponding countermeasures in the report, particularly in the section discussing future development[4]. - The company is addressing cyclical industry risks by closely monitoring macroeconomic conditions and downstream market demands, which significantly impact the fluorochemical sector[116]. - The company is facing a cyclical downturn in the fluorochemical industry, primarily due to oversupply and price declines[111]. - The company anticipates that the supply-demand relationship will improve as HFCs quota policies are implemented and industry capacity contracts during the downturn[111]. - The company is monitoring foreign exchange risks related to its export activities and will utilize financial instruments like forward contracts to mitigate these risks[120]. Environmental and Social Responsibility - The company invested 13.8011 million yuan in environmental protection during the reporting period[168]. - The total emissions of nitrogen oxides were 3.6193 tons, with a concentration of 11.627 mg/m³, well below the standard of 35 mg/m³[169]. - The total emissions of sulfur dioxide were 0.8513 tons, with a concentration of 2.683 mg/m³, below the standard of 50 mg/m³[169]. - The company has established an environmental protection mechanism and is classified as a key pollutant discharge unit[168]. - The company has implemented emergency response plans for environmental incidents, including comprehensive and specialized plans for hazardous chemical accidents and flood prevention[174]. - The company invested 2.8578 million yuan in social responsibility initiatives, benefiting 4,526 individuals through various charitable activities[183]. Research and Development - The company has invested in 28 R&D projects focusing on optimizing production processes and developing new products, including environmentally friendly refrigerants and fine chemicals[87]. - The company holds 96 authorized patents and has 43 pending patent applications, primarily in the fields of production processes and environmental technologies[87]. - Research and development expenses rose by 42.82% to CNY 38,310,662.41, reflecting increased investment in R&D projects[48]. Production Capacity and Operations - The company has a production capacity of 131,000 tons for anhydrous hydrofluoric acid (AHF), which helps in managing costs and enhancing profitability[26]. - The company has a production capacity of 65,000 tons for HFC-134a, 52,000 tons for HFC-125, 40,000 tons for HFC-32, and 10,000 tons for HFC-143a, making HFCs refrigerants the company's primary product[41]. - The company has a production capacity of 14,400 tons for HCFC-22, with 11,800 tons allocated for refrigerant production, accounting for 5.25% of the national production quota[37]. - The company has a production capacity of 35,600 tons for HCFC-141b, with 28,000 tons allocated for foaming agent production, representing 55.05% of the national production quota[38]. - The company is expanding AHF production capacity from 31,000 tons to 90,000 tons through ongoing projects[97]. Market Position and Strategy - The company is focusing on the integration of the industrial chain with investments in fluorinated refrigerants, fine chemicals, and polymers to foster new growth points[32]. - The company aims to become a leading manufacturer of refrigerants and fluorinated chemicals, with a focus on HFCs and fluoropolymer products[112]. - The company is committed to maintaining its market position in HFCs refrigerants while developing new environmentally friendly refrigerants and expanding into high-value products like fluoropolymers and fine chemicals[117]. Shareholder Engagement - The company ensures that minority shareholders have sufficient opportunities to express their opinions and that their legal rights are fully protected[159]. - The independent directors have fulfilled their responsibilities and played a significant role in the decision-making process regarding profit distribution[159]. - The company has committed to repurchase all newly issued shares within 3 trading days if any false statements or omissions are identified in the prospectus, with the repurchase price being the lower of the market price or the issuance price[194].

浙江三美化工股份有限公司 关于召开 2022 年度业绩说明会的公告 证券代码：603379 证券简称：三美股份 公告编号：2023-023 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 浙江三美化工股份有限公司（以下简称"公司"）于 2023 年 4 月 21 日发布 公司 2022 年年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营 成果、财务状况，公司计划于 2023 年 5 月 4 日下午 15:00-16:00 举行 2022 年度 业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内 就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 会议召开时间：2023 年 05 月 04 日（星期四）下午 15:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http: ...

Financial Performance - The company's operating revenue for Q3 2022 was CNY 1,199,272,857.41, representing a year-on-year increase of 23.54%[4] - The net profit attributable to shareholders for the same period was CNY 117,708,982.93, up 15.98% compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 33.66% year-on-year, totaling CNY 116,987,682.07[4] - Total operating revenue for the first three quarters of 2022 reached ¥3,768,143,775.51, a significant increase of 37.5% compared to ¥2,738,821,996.93 in the same period of 2021[15] - Net profit for Q3 2022 was ¥461,728,475.61, representing a 90.0% increase from ¥242,980,284.85 in Q3 2021[16] - Total comprehensive income for Q3 2022 was ¥461,725,746.66, compared to ¥242,960,295.82 in Q3 2021, reflecting strong growth[17] Earnings and Shareholder Information - The basic earnings per share for the year-to-date period was CNY 0.76, reflecting a 90.00% increase year-on-year[4] - Basic and diluted earnings per share for Q3 2022 were both ¥0.76, up from ¥0.40 in Q3 2021[17] - The company reported a total of 21,390 common shareholders at the end of the reporting period[9] - The top shareholder, Hu Rongda, holds 37.83% of the shares, totaling 230,913,959 shares[9] Assets and Liabilities - The total assets at the end of the reporting period reached CNY 6,414,603,121.92, a 6.01% increase from the end of the previous year[5] - As of September 30, 2022, the company's total assets amounted to RMB 6,414,603,121.92, an increase from RMB 6,051,148,356.58 at the end of 2021, reflecting a growth of approximately 6%[12][14] - The company's total liabilities decreased to RMB 736,128,958.99 from RMB 762,777,536.01, showing a reduction of about 3.5%[14] - The total equity attributable to shareholders increased to RMB 5,678,474,162.93 from RMB 5,288,370,820.57, marking an increase of approximately 7.4%[14] Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 169.44% year-on-year, amounting to CNY 598,794,811.41[4] - Cash flow from operating activities for the first three quarters of 2022 was ¥2,921,995,958.27, up 54.8% from ¥1,887,278,295.71 in the same period of 2021[18] - Net cash flow from operating activities in Q3 2022 was ¥598,794,811.41, a substantial increase from ¥222,239,854.47 in Q3 2021[19] - The company reported a net cash inflow from investment activities of ¥1,158,965,137.97 in Q3 2022, a turnaround from a net outflow of -¥1,199,188,025.73 in Q3 2021[19] Costs and Expenses - Total operating costs for the first three quarters of 2022 were ¥3,170,178,937.53, up 32.2% from ¥2,398,628,857.26 in the first three quarters of 2021[15] - R&D expenses in Q3 2022 amounted to ¥26,314,646.13, an increase of 32.0% compared to ¥19,955,443.97 in Q3 2021[16] - The company’s tax expenses for Q3 2022 were ¥150,632,648.64, compared to ¥86,940,021.07 in Q3 2021, indicating increased profitability[16] Inventory and Receivables - Accounts receivable decreased to RMB 441,733,243.32 from RMB 636,633,697.92, representing a decline of approximately 31%[12] - The company's inventory decreased to RMB 453,491,649.59 from RMB 502,806,589.86, reflecting a decline of about 9.8%[12] - The company reported a significant reduction in other receivables, which fell to RMB 23,939,032.96 from RMB 64,907,016.88, a decrease of approximately 63%[12] Cash and Cash Equivalents - The company's cash and cash equivalents reached RMB 3,400,122,437.60, significantly up from RMB 1,612,620,164.27 in the previous year, indicating an increase of about 110%[12] - The total cash and cash equivalents increased by $1,803,425,273.33, compared to a decrease of $1,051,682,863.04 in the prior year[20] - The ending balance of cash and cash equivalents reached $3,371,162,437.60, up from $1,432,451,656.62 in the previous period[20] - The impact of exchange rate changes on cash and cash equivalents was $67,604,002.20, contrasting with -$7,581,997.71 in the prior year[20]